Gyre Therapeutics, Inc. Investment Income, Net
Gyre Therapeutics, Inc. (GYRE) reported Investment Income, Net of $61.00 thousand for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-07-31.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2015-07-31
- Gyre Therapeutics, Inc. investment income, net for the quarter ending 2015-06-30 was $61.00K, a 60.39% decline year-over-year.
- Gyre Therapeutics, Inc. investment income, net for the quarter ending 2015-03-31 was $92.00K, a 48.31% decline year-over-year.
- Gyre Therapeutics, Inc. investment income, net for the quarter ending 2014-12-31 was $109.00K, a 36.63% decline year-over-year.
- Gyre Therapeutics, Inc. investment income, net for the quarter ending 2014-09-30 was $144.00K, a 43.97% decline year-over-year.
- Gyre Therapeutics, Inc. investment income, net for fiscal 2014 was $585.00K, a 25.38% decline from fiscal 2013.
- Gyre Therapeutics, Inc. investment income, net for fiscal 2013 was $784.00K, a 26.73% decline from fiscal 2012.
- Gyre Therapeutics, Inc. investment income, net for fiscal 2012 was $1.07M, a 20.62% decline from fiscal 2011.
- Gyre Therapeutics, Inc. investment income, net for fiscal 2011 was $1.35M.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2015-06-30 | $61.00K 10-Q · filed 2015-07-31 | $153.00K 10-Q · filed 2015-07-31 | $262.00K derived: sum of 3 quarters · filed 2015-07-31 | $406.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2015-03-31 | $92.00K 10-Q · filed 2015-05-07 | $201.00K derived: sum of 2 quarters · filed 2015-05-07 | $345.00K derived: sum of 3 quarters · filed 2015-05-07 | $499.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2014-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $253.00K derived: sum of 2 quarters · filed 2015-03-16 | $407.00K derived: sum of 3 quarters · filed 2015-07-31 | $585.00K 10-K · filed 2015-03-16 |
| 2014-09-30 | $144.00K 10-Q · filed 2014-11-06 | $298.00K derived: sum of 2 quarters · filed 2015-07-31 | $476.00K 10-Q · filed 2014-11-06 | $648.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2014-06-30 | $154.00K 10-Q · filed 2015-07-31 | $332.00K 10-Q · filed 2015-07-31 | $504.00K derived: sum of 3 quarters · filed 2015-07-31 | $761.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2014-03-31 | $178.00K 10-Q · filed 2015-05-07 | $350.00K derived: sum of 2 quarters · filed 2015-05-07 | $607.00K derived: sum of 3 quarters · filed 2015-05-07 | $738.00K derived: sum of 4 quarters · filed 2015-05-07 |
| 2013-12-31 | $172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $429.00K derived: sum of 2 quarters · filed 2015-03-16 | $560.00K derived: sum of 3 quarters · filed 2015-03-16 | $784.00K 10-K · filed 2015-03-16 |
| 2013-09-30 | $257.00K 10-Q · filed 2014-11-06 | $388.00K derived: sum of 2 quarters · filed 2014-11-06 | $612.00K 10-Q · filed 2014-11-06 | $864.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $131.00K 10-Q · filed 2014-08-07 | $355.00K 10-Q · filed 2014-08-07 | $607.00K derived: sum of 3 quarters · filed 2015-03-16 | $846.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $224.00K 10-Q · filed 2014-05-08 | $476.00K derived: sum of 2 quarters · filed 2015-03-16 | $715.00K derived: sum of 3 quarters · filed 2015-03-16 | $995.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $491.00K derived: sum of 2 quarters · filed 2015-03-16 | $771.00K derived: sum of 3 quarters · filed 2015-03-16 | $1.07M 10-K · filed 2015-03-16 |
| 2012-09-30 | $239.00K 10-Q · filed 2013-11-06 | $519.00K derived: sum of 2 quarters · filed 2013-11-06 | $818.00K 10-Q · filed 2013-11-06 | |
| 2012-06-30 | $280.00K 10-Q · filed 2013-08-07 | $579.00K 10-Q · filed 2013-08-07 | ||
| 2011-12-31 | $1.35M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |